A novel GH secretagogue, A233, exhibits enhanced growth activity and innate immune system stimulation in teleosts fish.
In teleosts fish, secretion of GH is regulated by several hypothalamic factors that are influenced by the physiological state of the animal. There is an interaction between immune and endocrine systems through hormones and cytokines. GH in fish is involved in many physiological processes that are not overtly growth related, such as saltwater osmoregulation, antifreeze synthesis, and the regulation of sexual maturation and immune functions. This study was conducted to characterize a decapeptide compound A233 (GKFDLSPEHQ) designed by molecular modeling to evaluate its function as a GH secretagogue (GHS). In pituitary cell culture, the peptide A233 induces GH secretion and it is also able to increase superoxide production in tilapia head-kidney leukocyte cultures. This effect is blocked by preincubation with the GHS receptor antagonist [d-Lys(3)]-GHRP6. Immunoneutralization of GH by addition of anti-tilapia GH monoclonal antibody blocked the stimulatory effect of A233 on superoxide production. These experiments propose a GH-mediated mechanism for the action of A233. The in vivo biological action of the decapeptide was also demonstrated for growth stimulation in goldfish and tilapia larvae (P<0.001). Superoxide dismutase levels, antiprotease activity, and lectin titer were enhanced in tilapia larvae treated with this novel molecule. The decapeptide A233 designed by molecular modeling is able to function as a GHS in teleosts and enhance parameters of the innate immune system in the fish larvae.
Biotechnology Animal Division, Aquatic Biotechnology Department, CIGB, Havana 10600, Cuba.
Rebeca
R
Martinez
Kenia
K
Ubieta
Fidel
F
Herrera
Alina
A
Forellat
Reynold
R
Morales
Ania
A
de la Nuez
Rolando
R
Rodriguez
Osvaldo
O
Reyes
Ayme
A
Oliva
Mario P
MP
Estrada
D000818:Animals; D017756:Aquaculture / Q000379:methods; D001681:Biological Assay; D002478:Cells, Cultured; D006054:Goldfish / Q000254:growth & development* / Q000276:immunology; D013006:Growth Hormone / Q000378:metabolism*; D007113:Immunity, Innate / Q000187:drug effects* / Q000276:immunology; D008958:Models, Molecular; D009842:Oligopeptides / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology*; D036361:Peptide Hormones / Q000494:pharmacology; D010902:Pituitary Gland / Q000166:cytology; D013482:Superoxide Dismutase / Q000378:metabolism; D013481:Superoxides / Q000378:metabolism; D017210:Tilapia / Q000254:growth & development* / Q000276:immunology
D009842:Oligopeptides; D036361:Peptide Hormones; D013481:Superoxides; C041048:growth hormone releasing hexapeptide; D013006:Growth Hormone; D013482:Superoxide Dismutase